Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world observational study of denosumab in postmenopausal fragility fracture
ChiCTR2400082544Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Apr 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of denosumab in osteoporosis and fragility fracture, sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: New fracture incidence. Started Apr 2024; status: recruiting.
02
Drugs
denosumab
03
Conditions
osteoporosisfragility fracture
Beyond the preview
Go deeper on ChiCTR2400082544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082544.